Literature DB >> 7569013

Late effects consensus conference: RTOG/EORTC.

.   

Abstract

Mesh：

Year:  1995        PMID： 7569013

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


× No keyword cloud information.
  17 in total

1.  Transanal endoscopic microsurgery for rectal cancer. Long-term oncologic results.

Authors:  Jose M Ramirez; Vicente Aguilella; Javier Valencia; Javier Ortego; Jose A Gracia; Pilar Escudero; Ricardo Esco; Mariano Martinez
Journal:  Int J Colorectal Dis       Date:  2011-01-27       Impact factor: 2.571

2.  Are endometrial cancer radiotherapy results age related?

Authors:  Á Rovirosa; K S Cortés; C Ascaso; A Glickman; S Valdés; A Herreros; C Camacho; J Sánchez; Y Zhang; Y Li; S Sabater; M Arenas; A Torne
Journal:  Clin Transl Oncol       Date:  2018-04-12       Impact factor: 3.405

3.  Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity scales: a survey of radiation oncologists.

Authors:  Minh-Phuong Huynh-Le; Zhe Zhang; Phuoc T Tran; Theodore L DeWeese; Daniel Y Song
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-13       Impact factor: 7.038

4.  Evaluation of parotid gland function following intensity modulated radiation therapy for head and neck cancer.

Authors:  Seok Ho Lee; Tae Hyun Kim; Joo Young Kim; Sung Yong Park; Hong Ryull Pyo; Kyung Hwan Shin; Dae Yong Kim; Joo Young Kim; Kwan Ho Cho
Journal:  Cancer Res Treat       Date:  2006-04-30       Impact factor: 4.679

5.  Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG).

Authors:  Hua-Chun Luo; Gui-Shan Lin; Shao-Guang Liao; Feng-Mei Wang; Hui-Hua Cheng; Jing Feng; Qin Yin; Qun-Hua Chen; Jin-Feng Zhu; Jian-Feng Xu; Dian Wang; Zhi-Chao Fu
Journal:  Br J Radiol       Date:  2017-12-05       Impact factor: 3.039

6.  Three or four fractions per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. The long-term results on vaginal relapses and toxicity.

Authors:  I Valduvieco; Á Rovirosa; A Herreros; I Romera; I Ríos; C Ascaso; A Sánchez-Reyes; M Arenas; J Pahisa; A Biete
Journal:  Clin Transl Oncol       Date:  2012-12-21       Impact factor: 3.405

7.  Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients.

Authors:  I Ríos; A Rovirosa; C Ascaso; I Valduvieco; A Herreros; L Castilla; S Sabater; K Holub; J Pahisa; A Biete; M Arenas
Journal:  Clin Transl Oncol       Date:  2015-12-11       Impact factor: 3.405

8.  Daily schedule for high-dose-rate brachytherapy in postoperative treatment of endometrial carcinoma.

Authors:  Angeles Rovirosa; Izaskun Valduvieco; Carlos Ascaso; Antonio Herreros; Carlos Bautista; Ingrid Romera; Meritxell Arenas; Jaume Pahisa; Albert Biete
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

9.  Postoperative endometrial carcinoma treated with external beam irradiation plus vaginal-cuff brachytherapy. Is there a dose relationship with G2 vaginal complications?

Authors:  Yaowen Zhang; Carlos Ascaso; Antonio Herreros; Joan Sánchez; Sebastia Sabater; Marta Del Pino; Yan Li; Gabriela Gómez; Aureli Torné; Albert Biete; Ángeles Rovirosa
Journal:  Rep Pract Oncol Radiother       Date:  2020-01-14

10.  Vaginal cuff brachytherapy: do we need to treat to more than a two-centimeter active length?

Authors:  Garrett L Jensen; Parul N Barry; Harriet Eldredge-Hindy; Scott R Silva; Sarah L Todd; Kendall P Hammonds; Walker R Zimmerman; Daniel S Metzinger; Moataz N El-Ghamry
Journal:  J Contemp Brachytherapy       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.